Use App
Trending
News
Earnings
Newsletters
Advertise
All
DIA
1.12%
SPY
0.83%
QQQ
1.13%
Trending
SNDX
7.88%
TTD
3.84%
NEGG
38.24%
UUUU
2.48%
F
12.02%
DECK
15.10%
NEUP
52.62%
MU
5.80%
PMI
20.72%
B
1.69%
SNDX
7.88%
TTD
3.84%
NEGG
38.24%
UUUU
2.48%
F
12.02%
DECK
15.10%
NEUP
52.62%
MU
5.80%
PMI
20.72%
B
1.69%
home
Symbol
EXAS
EXAS
Exact Sciences Corp.
11,240
Mkt Cap
$12.28B
Volume
1.48M
52W High
$72.83
52W Low
$38.81
PE Ratio
-11.96
EXAS Fundamentals
Price
$64.71
Prev Close
$64.85
Open
$64.68
50D MA
$53.81
Beta
1.02
Avg. Volume
2.71M
EPS (Annual)
-$5.59
P/B
4.97
Rev/Employee
$394,123.86
PE Ratio
-11.96
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
News
all
press releases
Incyte Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
INCY eyes strong Q3 performance with Jakafi, Opzelura, and new launches like Niktimvo driving revenues.
Zacks
·
6h ago
Share to Feed
More News
Here's How Charles River Stock Is Placed Ahead of Q3 Earnings
CRL heads into Q3 earnings with steady RMS growth but faces DSA headwinds from tight biotech budgets.
Zacks
·
7h ago
Molina Healthcare Q3 Earnings Miss Estimates on Rising Expenses
MOH's Q3 earnings plunge 69% as rising medical and administrative costs offset higher premiums and revenue gains.
Zacks
·
1d ago
Is Exact Sciences (EXAS) Outperforming Other Medical Stocks This Year?
Here is how Exact Sciences (EXAS) and EssilorLuxottica Unsponsored ADR (ESLOY) have performed compared to their sector so far this year.
Zacks
·
1d ago
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Zacks
·
1d ago
If You Invested $1000 in Exact Sciences a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks
·
1d ago
Here's How Henry Schein Is Placed Ahead of Q3 Earnings
HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.
Zacks
·
1d ago
Bio-Techne Q1 Earnings Preview: What's in Store for the Stock?
TECH's Q1 results could reflect steady Protein Sciences growth but pressure in Spatial Biology amid NIH and biotech funding uncertainty.
Zacks
·
1d ago
BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth
Butterfly Network's Q3 earnings may have been shaped by iQ3 adoption, software growth and strategic progress.
Zacks
·
2d ago
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zacks
·
2d ago
Latest EXAS News
View
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile